Ringel MD - Search Results

1

Genetic variants in thyroid cancer distant metastases.

Justiniano SE, McElroy JP, Yu L, Yilmaz AS, Coombes KR, Senter L, Nagy R, Wakely P Jr, Volinia S, Vinco M, Giordano TJ, Croce CM, Saji M, Ringel MD. Justiniano SE, et al. Among authors: ringel md. Endocr Relat Cancer. 2016 Oct;23(10):L33-6. doi: 10.1530/ERC-16-0351. Epub 2016 Aug 19. Endocr Relat Cancer. 2016. PMID: 27542854 Free PMC article. No abstract available.

2

Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia.

Ringel MD, Saji M, Schwindinger WF, Segev D, Zeiger MA, Levine MA. Ringel MD, et al. J Clin Endocrinol Metab. 1998 Feb;83(2):554-9. doi: 10.1210/jcem.83.2.4536. J Clin Endocrinol Metab. 1998. PMID: 9467574

3

Overexpression and overactivation of Akt in thyroid carcinoma.

Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M. Ringel MD, et al. Cancer Res. 2001 Aug 15;61(16):6105-11. Cancer Res. 2001. PMID: 11507060

4

Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells.

Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M. Ringel MD, et al. J Clin Endocrinol Metab. 2002 May;87(5):2399. doi: 10.1210/jcem.87.5.8626. J Clin Endocrinol Metab. 2002. PMID: 11994395

5

Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.

Vasko V, Saji M, Hardy E, Kruhlak M, Larin A, Savchenko V, Miyakawa M, Isozaki O, Murakami H, Tsushima T, Burman KD, De Micco C, Ringel MD. Vasko V, et al. Among authors: ringel md. J Med Genet. 2004 Mar;41(3):161-70. doi: 10.1136/jmg.2003.015339. J Med Genet. 2004. PMID: 14985374 Free PMC article.

6

Controversies in the follow-up and management of well-differentiated thyroid cancer.

Ringel MD, Ladenson PW. Ringel MD, et al. Endocr Relat Cancer. 2004 Mar;11(1):97-116. doi: 10.1677/erc.0.0110097. Endocr Relat Cancer. 2004. PMID: 15027888 Review.

7

17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels.

Braga-Basaria M, Hardy E, Gottfried R, Burman KD, Saji M, Ringel MD. Braga-Basaria M, et al. Among authors: ringel md. J Clin Endocrinol Metab. 2004 Jun;89(6):2982-8. doi: 10.1210/jc.2003-031767. J Clin Endocrinol Metab. 2004. PMID: 15181088

8

Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells.

Miyagi E, Braga-Basaria M, Hardy E, Vasko V, Burman KD, Jhiang S, Saji M, Ringel MD. Miyagi E, et al. Among authors: ringel md. Mol Carcinog. 2004 Oct;41(2):98-107. doi: 10.1002/mc.20042. Mol Carcinog. 2004. PMID: 15378648

9

Akt: a potential target for thyroid cancer therapy.

Kada F, Saji M, Ringel MD. Kada F, et al. Among authors: ringel md. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Sep;4(3):181-5. doi: 10.2174/1568008043339857. Curr Drug Targets Immune Endocr Metabol Disord. 2004. PMID: 15379721 Review.

10

Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.

Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C. Weber F, et al. Among authors: ringel md. J Clin Endocrinol Metab. 2005 May;90(5):2512-21. doi: 10.1210/jc.2004-2028. Epub 2005 Feb 15. J Clin Endocrinol Metab. 2005. PMID: 15713710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters